Washing red cells after leucodepletion does not decrease human leukocyte antigen sensitization risk in patients with chronic kidney disease

Pediatric Nephrology

Volumn 29, Issue 10, 2014, Pages 2005-2011

  Aston, Antony ^a   Cardigan, Rebecca ^b   Bashir, Saber ^b   Proffitt, Susan ^b   New, Helen ^b   Brown, Colin ^b   Liesner, Ri ^a   Hennem, Sylvia ^a   Nulty, Helen ^a   Shaw, Olivia ^c   Vaughan, Robert ^c   Kim, Jon Jin ^a,d   Rees, Lesley ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b NHS BLOOD AND TRANSPLANT   (United Kingdom)

^c GSTS Pathology   (United Kingdom)

^d GUY S HOSPITAL   (United Kingdom)

Author keywords

Alloimmunization; Antibody; Blood product; Chronic kidney disease; Components; HLA; Transfusion; Transplantation

Indexed keywords

HLA ANTIBODY; LEUKOCYTE ANTIGEN; ALLOANTIBODY; HLA ANTIGEN;

ADOLESCENT; ANTIBODY SCREENING; ARTICLE; AUTOMATION; CHILD; CHILDHOOD DISEASE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; ERYTHROCYTE; ERYTHROCYTE WASHING; FEMALE; HLA SYSTEM; HUMAN; LEUCODEPLETION; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; PLASMA; PLASMA TRANSFUSION; PRIORITY JOURNAL; PROCEDURES CONCERNING CELLS; RETROSPECTIVE STUDY; RISK FACTOR; SENSITIZATION; STIMULUS; THROMBOCYTE; ADVERSE EFFECTS; BLOOD; ERYTHROCYTE TRANSFUSION; IMMUNOLOGY; LEUKAPHERESIS; PROCEDURES; RENAL INSUFFICIENCY, CHRONIC;

CHILD; ERYTHROCYTE TRANSFUSION; FEMALE; HLA ANTIGENS; HUMANS; ISOANTIBODIES; LEUKAPHERESIS; MALE; RENAL INSUFFICIENCY, CHRONIC;

EID: 84920938514     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-014-2823-6     Document Type: Article

References (26)

1. Yabu JM, Anderson MW, Kim D, Bradbury BD, Lou CD, Petersen J, Rossert J, Chertow GM, Tyan DB (2013) Sensitization from transfusion in patients awaiting primary kidney transplant. Nephrol Dial Transplant. doi:10.1093/ndt/gft362
2. Organ Procurement and Transplantation Network (OPTN) Kidney Transplantation Committee Report to the board of directors. http://optn.transplant.hrsa.gov/CommitteeReports/board_main_KidneyTransplantationCommittee_7_1_2011_10_38.pdf Accessed 30/9/2012
3. Scornik JC, Meier-Kriesche HU (2011) Blood transfusions in organ transplant patients: mechanisms of sensitization and implications for prevention. Am J Transplant 11:1785–1791
4. Scornik JC, Pfaff WW, Howard RJ, Fennell RS 3rd, Ramos E, Peterson JC, Neiberger R (1994) Increased antibody responsiveness to blood transfusions in pediatric patients. Transplantation 58:1361–1365
5. Vella JP, O'Neill D, Atkins N, Donohoe JF, Walshe JJ (1998) Sensitization to human leukocyte antigen before and after the introduction of erythropoietin. Nephrol Dial Transplant 13:2027–2032
6. Obrador GT, Macdougall IC (2013) Effect of red cell transfusions on future kidney transplantation. Clin Am Soc Nephrol 8:852–860
7. Gombos P, Opelz G, Scherer S, Morath C, Zeier M, Schemmer P, Susal C (2013) Influence of test technique on sensitization status of patients on the kidney transplant waiting list. Am J Transplant 13:2075–2082
8. Seftel MD, Growe GH, Petraszko T, Benny WB, Le A, Lee CY, Spinelli JJ, Sutherland HJ, Tsang P, Hogge DE (2004) Universal prestorage leukoreduction in Canada decreases platelet alloimmunization and refractoriness. Blood 103:333–339
9. McPherson ME, Anderson AR, Castillejo MI, Hillyer CD, Bray RA, Gebel HM, Josephson CD (2010) HLA alloimmunization is associated with RBC antibodies in multiply transfused patients with sickle cell disease. Pediatr Blood Cancer 54:552–558
10. Karpinski M, Pochinco D, Dembinski I, Laidlaw W, Zacharias J, Nickerson P (2004) Leukocyte reduction of red blood cell transfusions does not decrease allosensitization rates in potential kidney transplant candidates. J Am Soc Nephrol 15:818–824
11. van de Watering L, Hermans J, Witvliet M, Versteegh M, Brand A (2003) HLA and RBC immunization after filtered and buffy coat-depleted blood transfusion in cardiac surgery: a randomized controlled trial. Transfusion 43:765–771
12. Sparrow RL, Patton KA (2004) Supernatant from stored red blood cell primes inflammatory cells: influence of prestorage white cell reduction. Transfusion 44:722–730
13. Mancini R, Marinelli L, Mirante N, Gallo A, Matteocci A, Terlizzi F, Palange M, Fioravanti D, Donnini L, Pierelli L (2012) Evaluation of haemoglobin, haematocrit, haemolysis, residual protein content and leucocytes in 345 red blood cell concentrates used for the treatment of patients with beta-thalassaemia. Blood Transfus 10:39–44
14. Hiesse C, Busson M, Buisson C, Farahmand H, Bierling P, Benbunan M, Bedrossian J, Aubert P, Glotz D, Loirat C, Rondeau E, Viron B, Bleux H, Lang P (2001) Multicenter trial of one HLA-DR-matched or mismatched blood transfusion prior to cadaveric renal transplantation. Kidney Int 60:341–349
15. Aalten J, Bemelman FJ, van den Berg-Loonen EM, Claas FH, Christiaans MH, de Fijter JW, Hepkema BG, Hene RJ, van der Heide JJ, van Hooff JP, Lardy NM, Lems SP, Otten HG, Weimar W, Allebes WA, Hoitsma AJ (2009) Pre-kidney-transplant blood transfusions do not improve transplantation outcome: a Dutch national study. Nephrol Dial Transplant 24:2559–2566
16. Balasubramaniam GS, Morris M, Gupta A, Mesa IR, Thuraisingham R, Ashman N (2012) Allosensitization rate of male patients awaiting first kidney grafts after leuko-depleted blood transfusion. Transplantation 93:418–422
17. Pfaff WW, Howard RJ, Scornik JC, Day C, Renderer J, Scott J, Fennel RS, Peterson JC, Salomon DR, Patton PR (1989) Incidental and purposeful random donor blood transfusion. Sensitization and transplantation. Transplantation 47:130–133
18. Karahan GE, Kekik C, Oguz FS, Onal AE, Bakkaloglu H, Caliskan YK, Yazici H, Turkmen A, Aydin AE, Sever MS, Eldegez U, Carin MN (2010) Association of HLA phenotypes of end-stage renal disease patients preparing for first transplantation with anti-HLA antibody status. Ren Fail 32:380–383
19. Hirata AA, McIntire FC, Terasaki PI, Mittal KK (1973) Cross-reactions between human transplantation antigens and bacterial lipopolysaccharides. Transplantation 15:441–445
20. El Aggan HA, Sidkey F, El Gezery DA, Ghoneim E (2004) Circulating anti-HLA antibodies in patients with chronic hepatitis C: relation to disease activity. Egypt J Immunol 11:71–79
21. Katerinis I, Hadaya K, Duquesnoy R, Ferrari-Lacraz S, Meier S, van Delden C, Martin PY, Siegrist CA, Villard J (2011) De novo anti-HLA antibody after pandemic H1N1 and seasonal influenza immunization in kidney transplant recipients. Am J Transplant 11:1727–1733
22. Morales-Buenrostro LE, Terasaki PI, Marino-Vazquez LA, Lee JH, El-Awar N, Alberu J (2008) "Natural" human leukocyte antigen antibodies found in nonalloimmunized healthy males. Transplantation 86:1111–1115
23. El-Awar N, Terasaki PI, Nguyen A, Sasaki N, Morales-Buenrostro LE, Saji H, Maruya E, Poli F (2009) Epitopes of human leukocyte antigen class I antibodies found in sera of normal healthy males and cord blood. Hum Immunol 70:844–853
24. Pereira S, Perkins S, Lee JH, Shumway W, LeFor W, Lopez-Cepero M, Wong C, Connolly A, Tan JC, Grumet FC (2011) Donor-specific antibody against denatured HLA-A1: clinically nonsignificant? Hum Immunol 72:492–498
25. Poli F, Benazzi E, Innocente A, Nocco A, Cagni N, Gianatti A, Fiocchi R, Scalamogna M (2011) Heart transplantation with donor-specific antibodies directed toward denatured HLA-A*02:01: a case report. Hum Immunol 72:1045–1048
26. Ishibashi N, Ohto H, Ujiie N, Ariga H, Ishii T, Suzuki H (2003) Low frequency of observed anti-HLA among transfused preterm infants. Transfusion 43:663–667